1 Viswanathan K,Kilcullen N,Morrell C,et al.Heart-type fatty acid-bindingprotein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative.J Am Coll Cardiol,2010,55:2590-2598. 2 崔璐,陈星,周颖,等.FABPs 家族基因的研究进展.畜牧与兽医,2016,48 :128-131. 3 Cabré A,Babio N,Lázaro I,et al.FABP4 predicts atherogenic dyslipidemia development.The PREDIMED study.Atherosclerosis,2012,222:229-234. 4 Cabré A,Lázaro I,Girona J,et al.Plasma Fatty Acid-Binding Protein 4 Increases with Renal Dysfunction in Type 2 Diabetic Patients without Microalbuminuria.Clin Chem,2008,54:181-187. 5 Cabré A,Lázaro I,Girona J,et al.Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes.J Lipid Res,2008,49:1746-1751. 6 Cabré A,Lázaro I,Girona J,et al.Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients.Atherosclerosis,2007,195:150-158. 7 Aragonès G,Ferré R,Lázaro I,et al.Fatty acid-binding protein 4 is associated with endothelial dysfunction in patients with type2 diabete.Atherosclerosis,2010,213:239-331. 8 Coll B,Cabre A,Alonso-Villaverse C,et al.The fatty acid-binding protein 4 is a strong biomarker of metabolic syndrome and liodystrophy in HIV-infected patients.Atherosclerosis,2008,199:147-153. 9 Lázaro I,Díaz M,Cabré A,et al.Fatty acid-binding protein-4 plasma levels are associated to metabolic abnormalities and response totherapy in girls and young women with androgen excess.Gynecol.Endocrinol,2011,27:935-939. 10 Lázaro I,Ferré R,Plana N,et al.Lifestyle Changes Lower FABP4 Plasma Concentration in Patients With Cardiovascular Risk.Rev.Espaola Cardiol,2012,65:152-157. 11 Xu A,Wang Y,Xu JY,et al.Adipocyte Fatty Acid–Binding Protein Is a Plasma Biomarker Closely Associated with Obesity and Metabolic Syndrome.Clin Chem,2006,52:405-413. 12 Shum BO,Mackay CR,Gorgun CZ,et al.The adipocyte fatty acid-binding protein aP2 is required in allergic airway inflammation.Clin Invest,2006,116:2183-2192. 13 Hertzel AV,Bernlohr DA.The mammalian fatty acidbinding protein multigene family:molecular and genetic insights into function.Trends Endocrinol Metab,2000,11:175-180. 14 Maeda K,Cao H,Kono K,et al.Adipocyte macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes.Cell Metab,2005,1:107-119. 15 Smith AJ,Thompson BR,Sanders MA,et al.Interaction of the adipocyte fatty acid-binding protein with the hormone-sensitive lipase:regulation by fatty acids and phosphorylation.J Biol Chem,2007,282:32424-32432. 16 Harjes U,Bridges E,Gharpure KM,et al.Antiangiogenic and tumour inhibitory effects of downregulating tumour endothelial FABP4. Oncogene,2017,36:912-921. 17 Li Y,Sun Y,Jing L,et al.Lysosome Inhibitors Enhance the Chemotherapeutic Activity of Doxorubicin in HepG2 Cells.Chemotherapy,2017,62:85-93. 18 Nieman KM,Kenny HA,Penicka CV,et al.Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth.Nat Med,2011,17:1498-1503. 19 Tang Y,Geng Y,Luo J,et al.Downregulation of ubiquitin inhibits the proliferation and radioresistance of non-small cell lung cancer cells in vitro and in vivo.Sci Rep Sci,2015,30:476. 20 俞静,王凤良,陆澄.肥胖与乳腺癌患者腋窝淋巴结状态的相关性研究.南京医科大学学报,2015,35:207-210. 21 Sparano JA,Wang M,Zhao F,et al.Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer.Cancer,2012,118:5937-5946. 22 Guaita-Esteruelas S,Bosquet A,Saavedra P,et al.Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins.Mol Carcinog,2017,56:208-217. 23 Jin J,Zhang Z,Zhang S,et al.Fatty acid binding protein 4 promotes epithelial-mesenchymal transition in cervical squamous cell carcinoma through AKT/GSK3beta/Snail signaling pathway.Mol Cell Endocrinol,2018,461:155-164. 24 Lahmann PH,Cust AE,Friedenreich CM,et al.Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition.Int J Cancer,2010,126:2404-2415. 25 Hu J,Liu Z,Wang X.Does TP53 mutation promote ovarian cancer metastasis to omentum by regulating lipidmetabolism.Med Hypotheses,2013,81:515-520. 26 Makowski L,Zhou C,Zhong Y,et al.Obesity increases tumor aggressiveness in a genetically engineered mouse model of serous ovarian cancer.Gynecol Oncol,2014,133:90-97. 27 Nieman KM,Kenny HA,Penicka CV,et al.Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth.Nat Med,2011,30:1498-1503. 28 Gharpure KM,Pradeep S,Sans M,et al.FABP4 as a key determinant of metastatic potential of ovarian cancer.Nat Commun,2018,9:2923. 29 Tang Z,Shen Q,Xie H,et al.Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer.Oncotarget,2016,7:46253-46262. 30 Luo Y,Yang Z,Li D,et al.LDHB and FABP4 are Associated With Progression and Poor Prognosis of Pancreatic Ductal Adenocarcinomas.Appl Immunohistochem Mol Morphol.Appl Immunohistochem Mol Morphol,2017,25:351-357. 31 Laurent V,Guérard A,Mazerolles C,et al.Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity.Nat Commun,2016,7:10230. 32 Herroon MK,Rajagurubandara E,Hardaway AL,et al.Bone marrow adipocytes promote tumor growth in bone via FABP4-dependent mechanisms.Oncotarget,2013,4:2108-2123.